Stock Scorecard
Stock Summary for Haleon plc (HLN) - $10.07 as of 3/23/2026 7:50:54 PM EST
Total Score
9 out of 30
Safety Score
36 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HLN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HLN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HLN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HLN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HLN (36 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Financial Details for HLN
Company Overview |
|
|---|---|
| Ticker | HLN |
| Company Name | Haleon plc |
| Country | N/A |
| Description | Haleon plc (HLN) is a premier global consumer health company that specializes in providing innovative health solutions across key segments such as oral care, pain relief, respiratory health, and dietary supplements. Emerging from the spin-off of GlaxoSmithKline, Haleon is home to prestigious brands like Sensodyne, Panadol, and Voltaren, which consolidate its foothold in the multi-billion-dollar consumer health sector. The company is committed to sustainability and consumer-centric innovation, aiming to enhance the health outcomes of individuals worldwide. By leveraging robust market insights and operational efficiencies, Haleon is strategically positioned to drive growth and shareholder value amidst a dynamic industry landscape through focused investments and ongoing product enhancement. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 4/29/2026 |
Stock Price History |
|
| Last Day Price | 10.07 |
| Price 4 Years Ago | 7.62 |
| Last Day Price Updated | 3/23/2026 7:50:54 PM EST |
| Last Day Volume | 7,461,597 |
| Average Daily Volume | 8,933,858 |
| 52-Week High | 11.35 |
| 52-Week Low | 8.71 |
| Last Price to 52 Week Low | 15.61% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 43.26 |
| Sector PE | 98.23 |
| 5-Year Average PE | 19.88 |
| Free Cash Flow Ratio | 33.57 |
| Industry Free Cash Flow Ratio | 9.38 |
| Sector Free Cash Flow Ratio | 25.46 |
| Current Ratio Most Recent Quarter | 0.92 |
| Total Cash Per Share | 0.30 |
| Book Value Per Share Most Recent Quarter | 2.48 |
| Price to Book Ratio | 2.09 |
| Industry Price to Book Ratio | 2.94 |
| Sector Price to Book Ratio | 36.25 |
| Price to Sales Ratio Twelve Trailing Months | 4.15 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.43 |
| Sector Price to Sales Ratio Twelve Trailing Months | 8.03 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 4,453,918,000 |
| Market Capitalization | 44,850,954,260 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/10/2026 |
| Previous Dividend Amount | 0.0598 |
| Current Dividend Amount | 0.1307 |
| Total Years Dividend Increasing | 3 |
| Trailing Annual Dividend Rate | 0.18 |
| Trailing Annual Dividend Yield | 1.80% |
| Forward Annual Dividend Rate | 0.26 |
| Forward Annual Dividend Yield | 2.56% |
| 5-Year Dividend Payments Count | 7 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 41.81% |
| 3-Year Dividend Growth Rate Percentage | 19.09% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 33.32% |
| Dividend Payout Ratio | 37.63% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 92.00% |
| Annual Earnings Growth | 13.07% |
| Reported EPS 12 Trailing Months | 0.49 |
| Reported EPS Past Year | 0.34 |
| Reported EPS Prior Year | 10.59 |
| Net Income Twelve Trailing Months | 2,780,691,817 |
| Net Income Past Year | 1,630,468,421 |
| Net Income Prior Year | 1,442,000,000 |
| Quarterly Revenue Growth YOY | 0.60% |
| 5-Year Revenue Growth | 1.75% |
| Operating Margin Twelve Trailing Months | 22.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,321,672,815 |
| Total Cash Past Year | 1,321,672,815 |
| Total Cash Prior Year | 2,195,000,000 |
| Net Cash Position Most Recent Quarter | -6,341,327,185 |
| Net Cash Position Past Year | -6,341,327,185 |
| Long Term Debt Past Year | 7,663,000,000 |
| Long Term Debt Prior Year | 8,542,000,000 |
| Total Debt Most Recent Quarter | 7,663,000,000 |
| Equity to Debt Ratio Past Year | 0.68 |
| Equity to Debt Ratio Most Recent Quarter | 0.68 |
| Total Stockholder Equity Past Year | 16,396,129,908 |
| Total Stockholder Equity Prior Year | 16,166,000,000 |
| Total Stockholder Equity Most Recent Quarter | 16,396,129,908 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 4,738,673,098 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.06 |
| Free Cash Flow Past Year | 1,970,842,157 |
| Free Cash Flow Prior Year | 2,051,000,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.10 |
| MACD Signal | -0.08 |
| 20-Day Bollinger Lower Band | 9.07 |
| 20-Day Bollinger Middle Band | 10.18 |
| 20-Day Bollinger Upper Band | 11.29 |
| Beta | 0.25 |
| RSI | 44.07 |
| 50-Day SMA | 10.00 |
| 150-Day SMA | 9.10 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 3/21/2026 12:21:35 AM EST |